Replies to post #12639 on Amarin Corp Plc (AMRN)

[KCSVEN]

I believe this is the section or was there more to the answer

"So, we're calling today the highest prescribers and we're evaluating our effectiveness of our sales force relative to those highest prescribers.

At the same time, we're entertaining proposals from third parties that could give us greater reach or frequency if we need it. It's too early for us to have to make that decision. At this point in time, we've launched the MARINE indication in January and final decisions relative to sales force in December and we don't need to make that final decision at this stage relative to the ANCHOR indication. But we're also cognizant to the fact that, a deal for example co-promote deal that we are not doing just for this flash news headline.

We are going to do as deal that there is strong into metric into it for both sides, there have been too many co-promotes that the partner - and doesn't deliver. And we are really looking for value not just the metric is in maximizing the revenues, metric is maximizing value per share. So, we're evaluating a range of possibilities from doing it ourselves, we're doing with somebody else, but we don't need to be making that decision yet. - See more at: http://www.earningsimpact.com/Transcript/82999/AMRN/Canaccord-Genuityandapos;s-33rd-Annual-Growth-Conference/Page/13#sthash.w5kf1ejo.dpuf";